Agios Pharmaceuticals, Inc. SEC filings AGIO
Agios Pharmaceuticals, Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Dec 7, 2015. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 4 | Insider transaction | Oct 28, 2026 | Oct 26, 2026 |
| 144 | Notice of proposed sale | Oct 26, 2026 | — |
| 4 | Insider transaction | Oct 23, 2026 | Oct 21, 2026 |
| 144 | Notice of proposed sale | Oct 22, 2026 | — |
| 144 | Notice of proposed sale | Oct 21, 2026 | — |
| 4 | Insider transaction | Aug 6, 2026 | Aug 4, 2026 |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 3, 2026 | — |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 8, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 2, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| S-8 | Employee stock plan registration | Jun 18, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 13, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 13, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| 10-Q | Quarterly report | Apr 29, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2026 | Apr 29, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 144 | Notice of proposed sale | Apr 2, 2026 | — |
| 144 | Notice of proposed sale | Apr 2, 2026 | — |
| 144 | Notice of proposed sale | Apr 2, 2026 | — |
| 144 | Notice of proposed sale | Apr 2, 2026 | — |
| 144 | Notice of proposed sale | Apr 2, 2026 | — |
| 144 | Notice of proposed sale | Apr 2, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 12, 2026 | — |
| 10-K | Annual report | Feb 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2026 | Feb 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 9, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 144 | Notice of proposed sale | Jan 5, 2026 | — |
| 4 | Insider transaction | Jan 2, 2026 | Dec 30, 2025 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 30, 2025 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 30, 2025 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 30, 2025 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 30, 2025 |
| 144 | Notice of proposed sale | Dec 30, 2025 | — |
| 144 | Notice of proposed sale | Dec 30, 2025 | — |
| 144 | Notice of proposed sale | Dec 30, 2025 | — |
| 144 | Notice of proposed sale | Dec 30, 2025 | — |
| 144 | Notice of proposed sale | Dec 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 14, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 11, 2025 |
| 144 | Notice of proposed sale | Nov 12, 2025 | — |
| 4 | Insider transaction | Nov 3, 2025 | Oct 30, 2025 |
| 144 | Notice of proposed sale | Oct 30, 2025 | — |
| 10-Q | Quarterly report | Oct 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Oct 29, 2025 | Oct 27, 2025 |
| 144 | Notice of proposed sale | Oct 27, 2025 | — |
| 4 | Insider transaction | Oct 10, 2025 | Oct 8, 2025 |
| 144 | Notice of proposed sale | Oct 8, 2025 | — |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 30, 2025 | Sep 26, 2025 |
| 144 | Notice of proposed sale | Sep 30, 2025 | — |
| 144 | Notice of proposed sale | Sep 26, 2025 | — |
| 4 | Insider transaction | Sep 9, 2025 | Sep 5, 2025 |
| 4 | Insider transaction | Aug 29, 2025 | Aug 27, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 28, 2025 | — |
| 144 | Notice of proposed sale | Aug 27, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| 144 | Notice of proposed sale | Aug 8, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2025 | Aug 4, 2025 |
| 10-Q | Quarterly report | Jul 31, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2025 | Jul 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jul 15, 2025 | Jul 10, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jul 9, 2025 |
| 144 | Notice of proposed sale | Jul 10, 2025 | — |
| 4 | Insider transaction | Jul 10, 2025 | Jul 8, 2025 |
| 3 | Initial insider ownership | Jul 10, 2025 | Jul 8, 2025 |
| 144 | Notice of proposed sale | Jul 9, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2025 | Jul 3, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 7, 2025 | — |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 144 | Notice of proposed sale | Jul 1, 2025 | — |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 144 | Notice of proposed sale | Jun 24, 2025 | — |
| 144 | Notice of proposed sale | Jun 24, 2025 | — |
| 144 | Notice of proposed sale | Jun 24, 2025 | — |
| 144 | Notice of proposed sale | Jun 24, 2025 | — |
| 144 | Notice of proposed sale | Jun 24, 2025 | — |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| S-8 | Employee stock plan registration | Jun 18, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 13, 2025 | — |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Apr 10, 2025 | Apr 8, 2025 |
| 144 | Notice of proposed sale | Apr 8, 2025 | — |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 3 | Initial insider ownership | Mar 7, 2025 | Mar 5, 2025 |
| S-8 | Employee stock plan registration | Mar 5, 2025 | — |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 10-K | Annual report | Feb 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 1, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2025 | Jan 3, 2025 |
| 144 | Notice of proposed sale | Jan 3, 2025 | — |
| 4 | Insider transaction | Dec 13, 2024 | Dec 11, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Nov 13, 2024 | Nov 8, 2024 |
| 4 | Insider transaction | Nov 12, 2024 | Nov 7, 2024 |
| 4 | Insider transaction | Nov 12, 2024 | Nov 7, 2024 |
| 144 | Notice of proposed sale | Nov 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| 144 | Notice of proposed sale | Nov 7, 2024 | — |
| 144 | Notice of proposed sale | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Oct 31, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2024 | Oct 31, 2024 |
| 4 | Insider transaction | Sep 30, 2024 | Sep 26, 2024 |
| 4 | Insider transaction | Aug 13, 2024 | Aug 11, 2024 |
| 4 | Insider transaction | Aug 13, 2024 | Aug 11, 2024 |
| 4 | Insider transaction | Aug 12, 2024 | Aug 8, 2024 |
| 144 | Notice of proposed sale | Aug 8, 2024 | — |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AGIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1439222
- Former names
- AGIOS PHARMACEUTICALS INC (until Jul 16, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.